221 related articles for article (PubMed ID: 10048578)
1. Dual activities of 22-24 kDA basic fibroblast growth factor: inhibition of migration and stimulation of proliferation.
Piotrowicz RS; Maher PA; Levin EG
J Cell Physiol; 1999 Feb; 178(2):144-53. PubMed ID: 10048578
[TBL] [Abstract][Full Text] [Related]
2. Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation.
Garmy-Susini B; Delmas E; Gourdy P; Zhou M; Bossard C; Bugler B; Bayard F; Krust A; Prats AC; Doetschman T; Prats H; Arnal JF
Circ Res; 2004 May; 94(10):1301-9. PubMed ID: 15073041
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation.
Antoine M; Wirz W; Tag CG; Gressner AM; Wycislo M; Müller R; Kiefer P
Biochem Biophys Res Commun; 2006 Jul; 346(1):224-33. PubMed ID: 16756958
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
Odekon LE; Sato Y; Rifkin DB
J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
[TBL] [Abstract][Full Text] [Related]
5. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
6. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
Hasselaar P; Sage EH
J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
[TBL] [Abstract][Full Text] [Related]
7. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
8. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
[TBL] [Abstract][Full Text] [Related]
9. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF.
Gualandris A; Urbinati C; Rusnati M; Ziche M; Presta M
J Cell Physiol; 1994 Oct; 161(1):149-59. PubMed ID: 7929600
[TBL] [Abstract][Full Text] [Related]
10. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
11. The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro.
Schilling-Schön A; Pleyer U; Hartmann C; Rieck PW
Exp Eye Res; 2000 Dec; 71(6):583-9. PubMed ID: 11095910
[TBL] [Abstract][Full Text] [Related]
12. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
[TBL] [Abstract][Full Text] [Related]
13. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD
J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183
[TBL] [Abstract][Full Text] [Related]
14. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M
Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor-induced migration of endothelial cells.
Dollé JP; Rezvan A; Allen FD; Lazarovici P; Lelkes PI
J Pharmacol Exp Ther; 2005 Dec; 315(3):1220-7. PubMed ID: 16123305
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.
Vogel T; Guo NH; Guy R; Drezlich N; Krutzsch HC; Blake DA; Panet A; Roberts DD
J Cell Biochem; 1994 Mar; 54(3):299-308. PubMed ID: 8200910
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
19. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.
Hervé MA; Buteau-Lozano H; Mourah S; Calvo F; Perrot-Applanat M
Exp Cell Res; 2005 Sep; 309(1):24-31. PubMed ID: 15996656
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]